Cargando…
Clinical Relevance of Pharmacogenetics in Serotonin Syndrome
Serotonin syndrome is a predictable life-threatening condition that is caused by serotonergic stimulation of the central and peripheral nervous systems. A patient's genetic profile can amplify exposure risk as many serotonergic drugs are metabolized by CYP450 enzymes, and these enzymes may be a...
Autores principales: | Pandya, Dehuti, Tran, My, Verduzco-Gutierrez, Monica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568165/ https://www.ncbi.nlm.nih.gov/pubmed/33101751 http://dx.doi.org/10.1155/2020/8860434 |
Ejemplares similares
-
Relevance of G-quadruplex structures to pharmacogenetics
por: Cree, Simone L., et al.
Publicado: (2014) -
Linezolid-induced serotonin syndrome
por: Shouan, Anish, et al.
Publicado: (2020) -
Metoclopramide-induced Serotonin Syndrome
por: Harada, Taku, et al.
Publicado: (2017) -
Serotonin Syndrome in Critical Care
por: Miller, Daniel, et al.
Publicado: (2023) -
Serotonin syndrome triggered by postoperative administration of serotonin noradrenaline reuptake inhibitor (SNRI)
por: Takata, Junko, et al.
Publicado: (2019)